Jing Song Wang
Chief Executive Officer at HBM HOLDINGS LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peiqi Sun | M | - |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | 8 years |
| Yi Ping Rong | M | 47 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | 8 years |
| Robert Kamen | M | 79 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | 8 years |
| Song Li | M | 66 | 23 years | |
| Mai Jing Liao | M | 54 |
Hbm Suzhou Co. Ltd.
| 6 years |
| Zhi He Li | M | 70 | 6 years | |
| Feng Ren | M | 49 |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 years |
| Aleksandrs Zhavoronkov | M | - |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 6 years |
| Da Ming Li | M | 57 |
Jilin University
| 11 years |
| Hui Huang | M | 40 | 4 years | |
| Weihao Xu | M | 42 | 3 years | |
| Jun Gao | M | 48 | - | |
| Yi Fan Li | M | 55 | 6 years | |
| Li Gu | F | 55 | 1 years | |
| Albert Collinson | M | 66 | 1 years | |
| Yu Min Qiu | M | 51 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | 8 years |
| Yan Xia | M | 44 | 3 years | |
| Denitsa Milanova | M | 39 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 years |
| Roman Kyrychynskyi | M | 48 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 years |
| Xing Yu Lu | M | 36 | 3 years | |
| Jun Wang | F | 37 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 4 years |
| Ka Chi Yau | M | 66 | 3 years | |
| Xiao Ping Ye | M | 61 | 4 years | |
| Jun Feng Wang | M | 50 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | 6 years |
| Zheng Tian Lü | M | 60 | 9 years | |
| Wei Wei Chen | F | 58 | - | |
| Roger Pomerantz | M | 67 |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | 5 years |
| Erh Fei Liu | M | 65 | 6 years | |
| Zi Yun Cai | F | 51 | 7 years | |
| Abdul Ezaz Mutlib | M | 63 | 7 years | |
| Li Juan Han | F | 33 | 1 years | |
| Dong Mei Wang | M | 61 | 7 years | |
| Bin Ma | M | 52 | 5 years | |
| Hong Amy Que | M | 59 | 3 years | |
| Wei Wei Chen | F | - |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | - |
| Min Fang | M | 45 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 years |
| Sujata Rao | M | 64 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 2 years |
| Aleksandr Aliper | M | 34 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 6 years |
| Lei Meng | M | 41 | 3 years | |
| Christopher Borella | M | - |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | 4 years |
| Hao Wu | M | 56 | 2 years | |
| Jian Bin Sun | M | 52 | 5 years | |
| Qing Yang | F | 61 | 5 years | |
| Cai Hong Zheng | F | 54 | 7 years | |
| Kan Chen | M | 42 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 years |
| Ming Zi Chen | M | 54 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 years |
| Li Le Liu | M | 62 | 6 years | |
| Jian Wei Ma | M | 56 | 5 years | |
| Wing Yat Lui | M | 35 | - | |
| Yin Zhuan | F | 58 | 2 years | |
| Ying Lung Chang | F | 61 | - | |
| Humphrey Gardner | M | 60 | 2 years | |
| Kwan Wai Leung | F | 43 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 years |
| Cui Ping Gu | M | 44 |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | - |
| Richard Fischetti | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Xiao Xiang Chen | M | 54 | 6 years | |
| Tao Jing | M | 41 | 2 years | |
| Qian Liu | F | 59 |
Jilin University
| 6 years |
| Yan Song | F | 58 | 6 years | |
| Wen Yi Huang | M | 53 |
Jilin University
| 7 years |
| Atul Mukund Deshpande | M | 44 | 3 years | |
| Ben Niu | M | 43 |
China Pharmaceutical University
| 5 years |
| Mark Gilbert | M | 63 |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | 2 years |
| Ji Fan Gao | M | 59 |
Jilin University
| 1 years |
| Hui Ye Sun | M | 56 |
Jilin University
| 4 years |
| Hua Xin | M | 58 |
Jilin University
| 4 years |
| Xin Ming Zhang | M | 60 |
Jilin University
| 3 years |
| Xing Zhang | M | 54 |
Jilin University
| 3 years |
| Xue Jun Song | M | 61 |
Xuzhou Medical University
| 4 years |
| Zhi Hua Xu | M | 73 |
Jilin University
| 1 years |
| Yuan Zhi Tan | M | 52 |
Jilin University
| 4 years |
| Jin Mei Liu | F | 54 |
Jilin University
| 4 years |
| Qing Yan | M | 55 |
Jilin University
| 4 years |
| Ye Li Hao | M | 68 |
Jilin University
| 3 years |
| Jing Jin Yao | M | 61 |
Jilin University
| 1 years |
| Dong Yi Su | M | 58 |
Jilin University
| 4 years |
| Xiang En Shi | M | 68 |
Jilin University
| 3 years |
| Wei Dong Yuan | M | 55 |
Jilin University
| 4 years |
| Xi Hong Wu | M | 57 |
Jilin University
| 4 years |
| Dong Mei Su | M | 54 |
Jilin University
| 4 years |
| Jiang He | M | 52 |
Jilin University
| 4 years |
| Yun Tao Yang | M | 57 |
Jilin University
| 3 years |
| Wen Wei Dou | M | 58 |
Jilin University
| 3 years |
| Jin Li Wang | M | 64 |
Jilin University
| 4 years |
| Qing Dong Zeng | M | 60 |
Jilin University
| 1 years |
| GRANT Chen | M | 60 |
Jilin University
| 1 years |
| Qiang Liu | M | 58 |
Jilin University
| 4 years |
| Guang Yuan Wang | M | 62 |
Jilin University
| 4 years |
| Shi Ping Liang | M | 54 |
Jilin University
| 4 years |
| Jun Xu | M | 54 |
Jilin University
| 4 years |
| Ai Guo Kong | M | 57 |
Jilin University
| 4 years |
| Jin Hua Zhang | M | 59 |
Jilin University
| 4 years |
| Ying Ming Chen | M | 60 |
Jilin University
| 3 years |
| Tao Liu | F | 58 |
Jilin University
| 4 years |
| Shane Hu | M | - |
Jilin University
| 4 years |
| An Jian Wang | M | 71 |
Jilin University
| 3 years |
| Gui Lin Zhao | M | 60 |
Jilin University
| 1 years |
| Zheng Mao Zhou | M | 52 |
Jilin University
| 4 years |
| Hai Tian Zhang | M | 55 |
Jilin University
| 4 years |
| Sheng Jun Luo | M | 54 |
Jilin University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 73 | 73.00% |
| United States | 16 | 16.00% |
| Hong Kong | 11 | 11.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jing Song Wang
- Personal Network
